Scholars Central

Short communicationPublished 5 Sep 2020

Increasing the quality of life in NSCLC patients by obdivo and taxoter with hyperthermia

Authors: S Badzgaradze

Journal of Cancer Clinical Research

Volume 3 · Issue 3 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Topicality: Treatment of oncological patients and getting clinical remission is an unfortunate Topic even for the 21st century; despite the correctly selected therapy, which gives minimal Risks of complications because of the chemo sensitive tests, there are important problems Connected with the quality of life of patients and naturally we ask questions to ourselves: How could we manage to increase the quality of life in oncological patients on the 3rd and 4th levels and decrease the number of the side effects that accompany Ch/therapy and R/therapy procedures. Aim: The aim of the study was the patient with a 55-year diagnosis: NSCLC Thigh bone MTS, 3rd stage; R /therapy and 4 Courses CH /therapy; ECOG-2. Clinical remission was not achieved; Symptoms of progression of the hip fracture were Strengthened, and the institution was addressed with the aforementioned history. Methods and Materials: For the patient was selected CH/courses with hyperthermia and target therapy, we use Docetaxel 80 mg / m2 and oblivion recommended to strengthen the course effectiveness, weaken toxicity and to improve the quality of life recommended for the treatment CH/therapy + target therapy with hyperthermia and hypoglycaemia; For this procedure, a hyperthermic camera was installed, where the procedure is carried out at 43-48 degrees Celsius, and we have a sugar content of 25-30000 per one 40-45 mm / l in the bloodstream

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cancer Clinical Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “S Badzgaradze”